Jun 26, 2019

Motus GI Announces Pricing of $20 Million Public Offering of Common Stock

Jun 26, 2019

Motus GI Announces Proposed Public Offering of Common Stock

Jun 19, 2019

Motus GI Bolsters Commercial and Quality/Regulatory Expertise with Two Key Senior Management Additions

Jun 18, 2019

Motus GI to Present at the JMP Securities Life Sciences Conference

Jun 11, 2019

Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2

May 20, 2019

Motus GI Presents Positive Clinical Results from REDUCE Study Evaluating Pure-Vu® System in Hospitalized Colonoscopy Patients at Digestive Disease Week® 2019

May 15, 2019

Motus GI to Present at the 20th Annual B. Riley FBR Investor Conference

May 10, 2019

Motus GI Reports First Quarter 2019 Financial Results and Provides Corporate Update

Apr 29, 2019

Motus GI to Present Clinical Results from REDUCE Study Evaluating the Pure-Vu® System at Digestive Disease Week® 2019

Mar 27, 2019

Motus GI Reports Full Year 2018 Financial Results and Provides Business Outlook